CONGRESS HEALTH & RESEARCH FORUM 2020
Capacity limited to the size of the room.
Congress coordinator Dr. Begoña Aguado, scientific supervisor of the Genomics and Mass Sequencing Service of the Centro de Biología Molecular Severo Ochoa (CBMSO), CSIC-UAM.

 

15th April (Lilly’s Room)

General Topic: Oncology

Morning:

  • 10:00 a 12:00. FEBIOTEC round table: New approaches in oncology and their clinical implementation. Moderator: Álvaro Rodríguez-Lescure, president of the SEOM (Spanish Society of Medical Oncology) and Head of the Medical Oncology Service of the Hospital General Universitario de Elche.
    • Two decades of Precision Medicine: Achievements and Challenges – Mariano Barbacid, AXA-CNIO professor of molecular oncology, Centro Nacional de Investigaciones Oncológicas (CNIO), Spanish National Cancer Research Center.
    • Basic research in oncology from a research center’s point of view – Miguel Ángel Quintela, director of the Clinical Research Unit of the CNIO.
    • Clinical implantation with patients – Iván Márquez Rodás, coordinator of the Hereditary Cancer Unit (Hospital Gregorio Marañón).
    • What is being researched/developed from the company? especially in preventive diagnosis/monitoring – Cristina Pérez-Sánchez, Business Project Manage Atrys Health.
  • 12:00 a 12:30. COFFEE BREAK
  • 12:30 a 14:00. Treating Oncology
    • New immunotherapeutic strategies against acute lymphoblastic leukaemia (T-ALL) – Maria Luisa Toribio, research professor at CSIC. Centro de Biología Molecular Severo Ochoa (CBMSO), CSIC-UAM.
    • New prognostic/differential diagnosis markers for leukaemia – Manuel Fresno Escudero, Professor of Microbiology – Universidad Autónoma de Madrid / Head of the research line at the Centro de Biología Molecular Severo Ochoa (CBMSO), CSIC-UAM.
    • Liquid biopsy and the theory of genometastasis – Damián García Olmo, Professor of Surgery at the Universidad Autónoma de Madrid (UAM), Head of the Department of Surgery. Fundación Jiménez Díaz-Quirón Salud (Madrid).
    • Translational biology: advanced cellular tests in oncology – Juan Velasco, director of the Research, Development and Innovation Centre of Lilly España.
    • Nimgenetics’ Genomic Approaches to Oncology Diagnosis – Enric Samper, CEO Nimgenetics.

 

Afternoon:

  • 15:30 a 17:00. ASEBIO Round Table: Cancer Immunology: a Revolution in Progress. Moderator: Ion Arocena, General Director of ASEBIO, Spanish Association of Biocompanies.
    • José Cabrera, Medical Director of Bristol-Myers Squibb.
    • María Victoria Tornamira, medical director of oncology for Spain at MSD.
    • Eva López, medical director of Novartis Oncology.
  • 17:00 a 18:30. Round Table BIOCLUSTERS.
    • Onkologikoa Foundation: An approach to oncology R&D from the point of view of business co-participation. – Ander Urruticoechea, Scientific Director at Onkologikoa. Member of the Basque Health Cluster.
    • Discovery and development of new immunotherapies for the restricted treatment of colorectal cancer.Ramón Bosser, CEO Origo Biopharma. Member of Bioga.
    • Oncoheroes: From the idea to the patient. – Eva Méndez, head of drug discovery of Oncoheroes Biosciences Inc. (CataloniaBio & HealthTech member).

 

16th April (Lilly’s Room)

Morning:

General Topic: Neurology

  • 09:30 a 11:00. Treating Neurology.
    • From basic research to therapeutic strategies for diseases of the nervous system – Jose Javier Lucas, CSIC research professor, group leader of the Centro de Biología Molecular-Severo Ochoa (CBMSO), CSIC-UAM.
    • Neuronal regeneration in Alzheimer’s disease – María Llorens-Martín, researcher “Ramón y Cajal” UAM Centro de Biología Molecular Severo Ochoa (CBMSO), CSIC-UAM.
    • Research and search for therapies for rare neurological diseases with impact on children – María Dolores Ledesma, scientific researcher at CSIC Centro Biología Molecular Severo Ochoa (CBMSO), CSIC-UAM.
    • How can Artificial Intelligence accelerate the discovery of new therapies in the field of neurology? – Teresa Sardón, senior researcher and business unit manager at Anaxomics.

 

General Topic: Financing

  • 11:00 a 12:15. Dealing with Financing.
    • Different aids for R+D+i of the CDTI – Juan Luis Romera Santiago, manager-technician of the Department of Institutional Promotion and Territorial Cooperation, of the CDTI.
    • State Research Agency. Speaker to be confirmed.
    • InnorMadrid. Promoting public-private collaboration: no good project should go unfunded.Isabel García Carneros, Managing Director.
  • 12:15 a 12:45. COFFEE BREAK

 

General Topic: Vaccines

  • 12:45 a 14:15. Treating Vaccines
    • Vaccine strategies in a changing society – Margarita del Val, scientific researcher at CSIC Centro de Biología Molecular Severo Ochoa (CBMSO), CSIC-UAM.
    • Vaccines against leishmaniasis: between interest and oblivion – José María Requena Rolanía, Professor of the Department of Molecular Biology (UAM), Centro de Biología Molecular Severo Ochoa (CBMSO), CSIC-UAM.
    • Physics of viruses for the development of vaccines and antiviral drugs – Mauricio García Mateu, Professor of Biochemistry and Molecular Biology UAM and Centro de Biología Molecular Severo Ochoa (CBMSO), CSIC-UAM.